05:38 PM EST, 11/10/2025 (MT Newswires) -- Neil Kumar, Director, Chief Executive Officer, on November 06, 2025, sold 80,000 shares in Bridgebio Pharma ( BBIO ) for $4,983,111. Following the Form 4 filing with the SEC, Kumar has control over a total of 1,018,776 common shares of the company, with 223,090 shares held directly and 795,686 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1743881/000147083125000302/xslF345X05/wk-form4_1762814033.xml